Chris Thomajan has been a CFO for over 25 years in a variety of industries, including: biotech, medtech, software, digital media, Internet services and investment banking.
Chris was a founding partner of America’s Growth Capital, a boutique investment bank focused on emerging growth technology companies. He was the early stage CFO/VP Operations for Asurion Corporation which is a closely held, multi-billion-dollar private company. He was also the founding CFO for a pioneering Internet company, Delphi Internet Services, which was acquired by News Corporation in 1993. Since joining TechCXO in 2007, Chris has worked with outstanding companies such as Mashable, Adheron (acquired by Roche in October 2015), Decibel Therapeutics, Relay Therapeutics, Mascoma Corp., Lycera Corp. Catabasis Pharmaceuticals (IPO in June 2015), and Ektron (acquired by Accel/KKR in December 2014).
Chris has extensive experience in raising debt and equity. He has also been involved in numerous M&A transactions and has managed the operations of several start-up companies during rapid revenue growth. He received a B.A. from Dartmouth College and an M.B.A. from Columbia University.
The Latest from Chris Thomajan
Infographic: 5 Financial Mistakes Startups Make
5 Most Common Financial Mistakes that Startups Make
I have been a CFO for over 25 years (I know, must have been 14 when I started) and have worked with 30+ early stage companies. Typically, these are venture-backed companies or ne...Full Article
TechCXO Client Relay Therapeutics Launched with $57M Series A
Chris Thomajan, TechCXO’s Managing Partner – Boston ( See Chris’ full bio) has been working with Relay Therapeutics since late 2015. TechCXO was hired to provide CFO lead...Full Article
Third Rock Ventures Launches Relay Therapeutics with $57 Million Series A Financing
Chris Thomajan, TechCXO's Managing Partner - Boston has been working with Relay Therapeutics since late 2015. TechCXO was hired to provide CFO leadership to Relay as well as a ...Full Article
Managing Capital Intensive Startups
All startups have challenges but those early stage companies in industries that require more up-front capital – without any internal cash flow to draw from -- have unique issue...Full Article